• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似凝血因子缺乏患者的即时检验凝血酶原时间(PT)和活化部分凝血活酶时间(aPTT)

Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.

作者信息

Niederdöckl J, Dempfle C-E, Schönherr H-R, Bartsch A, Miles G, Laggner A, Pathil A

机构信息

Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria.

Coagulation Center Mannheim, Mannheim, Germany.

出版信息

Int J Lab Hematol. 2016 Aug;38(4):426-34. doi: 10.1111/ijlh.12519. Epub 2016 Jul 7.

DOI:10.1111/ijlh.12519
PMID:27384253
Abstract

INTRODUCTION

There are several clinical settings and patient conditions especially in intensive care units, emergency departments, and operating theaters, where the coagulation status of a patient must be known immediately and point-of-care (POC) systems are beneficial due to low time to result.

METHODS

This noninterventional, single-blinded, multicenter study with prospectively collected whole blood samples was performed to evaluate the diagnostic accuracy of the CoaguChek PT Test (POC PT) and CoaguChek aPTT Test (POC aPTT) compared to standard laboratory testing in patients with suspected deficiencies of coagulation factors.

RESULTS

In total, 390 subjects were included. Both POC PT and POC aPTT showed concordance with the laboratory PT and aPTT. Lot-to-lot variation was below 2% both for POC PT and for POC aPTT. The mean relative difference of capillary blood compared to venous blood was 0.2 % with POC PT and 8.4% with POC aPTT. The coefficients of variation for repeatability of POC PT using whole blood were found to be between 2% and 3.6%.

CONCLUSION

Our findings suggest reliable quantitative results with this POC system to support on-site decision-making for patients with suspected deficiencies of coagulation factors in acute and intensive care.

摘要

引言

在多种临床环境和患者状况下,尤其是在重症监护病房、急诊科和手术室,必须立即了解患者的凝血状态,而即时检验(POC)系统因其出结果时间短而具有优势。

方法

本项非干预性、单盲、多中心研究,前瞻性收集全血样本,旨在评估与标准实验室检测相比,CoaguChek PT检测(POC PT)和CoaguChek aPTT检测(POC aPTT)在疑似凝血因子缺乏患者中的诊断准确性。

结果

共纳入390名受试者。POC PT和POC aPTT均与实验室PT和aPTT结果一致。POC PT和POC aPTT的批次间差异均低于2%。与静脉血相比,POC PT检测毛细血管血的平均相对差异为0.2%,POC aPTT检测为8.4%。使用全血时,POC PT重复性的变异系数在2%至3.6%之间。

结论

我们的研究结果表明,该POC系统可提供可靠的定量结果,有助于在急性和重症监护环境中为疑似凝血因子缺乏的患者进行现场决策。

相似文献

1
Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.疑似凝血因子缺乏患者的即时检验凝血酶原时间(PT)和活化部分凝血活酶时间(aPTT)
Int J Lab Hematol. 2016 Aug;38(4):426-34. doi: 10.1111/ijlh.12519. Epub 2016 Jul 7.
2
Do PT and APTT sensitivities to factors' deficiencies calculated by the H47-A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients?按照2008年CLSI H47 - A2指南计算的PT和APTT对凝血因子缺乏的敏感度是否反映了患者血浆中发现的凝血因子缺乏情况?
Int J Lab Hematol. 2015 Dec;37(6):853-60. doi: 10.1111/ijlh.12424. Epub 2015 Sep 4.
3
Point-of-care (POC) measurement of coagulation after cardiac surgery.心脏手术后凝血功能的床旁检测
Intensive Care Med. 1998 Nov;24(11):1187-93. doi: 10.1007/s001340050743.
4
On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.现场凝血酶原时间、活化部分凝血活酶时间及血小板计数。心脏手术患者全血检测与实验室检测及凝血因子分析的比较。
Anesthesiology. 1994 Feb;80(2):338-51. doi: 10.1097/00000542-199402000-00014.
5
Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study.出血性手术中床旁凝血检测与中心实验室凝血检测的比较:一项多中心研究
Thromb Haemost. 2009 Feb;101(2):394-401.
6
Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.使用即时凝血仪测定替拉万星对凝血酶原时间和活化部分凝血活酶时间的影响。
J Thromb Thrombolysis. 2014;38(2):235-40. doi: 10.1007/s11239-013-1004-y.
7
A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.单中心回顾性研究:门诊环境中凝血酶原时间和活化部分凝血活酶时间延长的原因。
Int J Lab Hematol. 2022 Feb;44(1):209-215. doi: 10.1111/ijlh.13727. Epub 2021 Oct 5.
8
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: an observational study on cord blood.用于新生儿凝血评估的GEM®PCL Plus即时检测设备的评估:一项关于脐带血的观察性研究。
Thromb Res. 2014 Aug;134(2):474-8. doi: 10.1016/j.thromres.2014.05.024. Epub 2014 May 27.
9
Point-of-care testing of neonatal coagulation.新生儿凝血的即时检验
Clin Lab Haematol. 2006 Apr;28(2):117-21. doi: 10.1111/j.1365-2257.2006.00765.x.
10
Comparison of five point-of-care prothrombin and activated partial thromboplastin time devices based on age of blood sample.基于血样保存时间对五种即时凝血酶原时间和活化部分凝血活酶时间检测设备的比较
J Extra Corpor Technol. 2002 Sep;34(3):178-81.

引用本文的文献

1
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART).SEVUparin作为重症疟疾儿童潜在辅助治疗方法:一项I期安全性和剂量探索试验(SEVUSMAART)。
Wellcome Open Res. 2024 Aug 12;8:484. doi: 10.12688/wellcomeopenres.20111.2. eCollection 2023.
2
Hemostasis-on-a-chip / incorporating the endothelium in microfluidic models of bleeding.基于芯片的止血/将内皮细胞纳入出血的微流控模型中。
Platelets. 2023 Dec;34(1):2185453. doi: 10.1080/09537104.2023.2185453.
3
Monitoring of Unfractionated Heparin Therapy in the Intensive Care Unit Using a Point-of-Care aPTT: A Comparative, Longitudinal Observational Study with Laboratory-Based aPTT and Anti-Xa Activity Measurement.
使用即时检验活化部分凝血活酶时间监测重症监护病房中普通肝素治疗:一项与基于实验室的活化部分凝血活酶时间和抗Xa活性测量的比较性纵向观察研究。
J Clin Med. 2022 Feb 28;11(5):1338. doi: 10.3390/jcm11051338.
4
Diagnostic Modalities in Critical Care: Point-of-Care Approach.重症监护中的诊断方法:床旁检测法
Diagnostics (Basel). 2021 Nov 25;11(12):2202. doi: 10.3390/diagnostics11122202.
5
Monitoring Anticoagulation with Unfractionated Heparin on Renal Replacement Therapy. Which is the Best aPTT Sampling Site?在肾脏替代治疗中监测普通肝素抗凝。最佳活化部分凝血活酶时间(aPTT)采样部位是哪里?
J Crit Care Med (Targu Mures). 2020 Aug 11;6(3):159-166. doi: 10.2478/jccm-2020-0024. eCollection 2020 Jul.
6
Technology Advancements in Blood Coagulation Measurements for Point-of-Care Diagnostic Testing.即时检验凝血测量的技术进展
Front Bioeng Biotechnol. 2019 Dec 11;7:395. doi: 10.3389/fbioe.2019.00395. eCollection 2019.